Stay updated on Atezolizumab Subq in NSCLC: Clinical Trial
Sign up to get notified when there's something new on the Atezolizumab Subq in NSCLC: Clinical Trial page.

Latest updates to the Atezolizumab Subq in NSCLC: Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoChange DetectedEnrollment updated to 438 and the last update date shown as 2025-06-12. The locations section appears expanded to include additional sites across multiple countries.SummaryDifference0.2%

- Check15 days agoNo Change Detected
- Check36 days agoChange DetectedUpdate includes a prominent operating-status notice and a version upgrade from v3.1.0 to v3.2.0. If no other content changes are present, this indicates readiness/maintenance rather than new features.SummaryDifference2%

- Check43 days agoChange DetectedUpdated the page version from v3.0.2 to v3.1.0, signaling a software/version update with no substantive content changes.SummaryDifference0.0%

- Check58 days agoChange DetectedPage updated to v3.0.2 from v3.0.1; 'Back to Top' element removed.SummaryDifference0.1%

- Check65 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes in core content, pricing, or availability.SummaryDifference0.1%

- Check72 days agoChange DetectedThe webpage has undergone significant updates, including the addition of new facility names and locations across various countries, as well as updated drug information for Atezolizumab. Notably, the previous version's drug information and location details have been largely replaced or removed.SummaryDifference10%

Stay in the know with updates to Atezolizumab Subq in NSCLC: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Atezolizumab Subq in NSCLC: Clinical Trial page.